• Print
return to Faculty and Departments


Thomas J. Long School of Pharmacy and Health Sciences Admissions
Office of the Dean
751 Brookside Road
Stockton, CA 95207
Mailing - 3601 Pacific Avenue Stockton, CA 95211

Wade A. Russu, Ph.D.

Associate Professor
Department of Pharmaceutics and Medicinal Chemistry 

Phone: 209.946.2339
Email: wrussu@pacific.edu 

Research Interests

  • Drug discovery, design and synthesis
  • Anti-cancer and anti-viral chemotherapeutics
  • Peptide and peptidomimetic design
  • Methodology for organic synthesis

Wade A. Russu graduated from California Polytechnic State University, San Luis Obispo with a bachelor of science in 1992 and received his doctor of philosophy from University of California, Santa Barbara in 2000. He underwent graduate training at the Cancer Research Institute, University of California, Irvine for two years, and also at the Institute for Brain Aging and Dementia, University of California, Irvine for two years as well. He has been at University of Pacific since 2005.

Dr. Russu is a California native and comes from a multicultural family. He is one of seven siblings, two of which were adopted from South America. His great-grandfather emigrated from Romania in 1910 and used to distill alcohol during the Prohibition, which may be where Dr. Russu's inclination for brewing beer came from. Dr. Russu is married with three children.

Shallal, H. M.; Faridi, J. S.; Russu, W. A. "Anti-tumor Pyrimidinylpiperazines bind to prosurvival Bcl-2 protein Family member Bcl-XL." Bioorg. Med. Chem. Lett. 2011, 21, 1325-1328.

Shallal, H. M.; Russu, W. A. "Discovery, Synthesis, and Investigation of the Antitumor Activity of Novel Piperazinylpyrimidine Derivatives." Euro. J. Med. Chem. 2011, 46, 2043-2057.

Phanidhara Kotamraj, Wade A. Russu, Bhaskara Jasti ‘95, Xiaoling Li, "Novel Integrin-Targeted Binding-Triggered Drug Delivery System for Methotrexate." Pharm. Res. 2011, 28, 3208-3219.

Hashemzadeh, M.; Movahed, M. R.; Russu, W. A.; Soroush, L.; Hill, D. N. "Novel design and synthesis of modified structure of carveldilol." Recent Pat. Cardiovasc. Drug Discov. 2011, 6, 175-179.